Answers are grounded in this paper and cite their sources.
• The 9-gene classifier was developed based on metastasis-related genes derived from gene expression profiles of soft tissue sarcoma. • The 9-gene classifier can predict metastatic risk of soft tissue sarcoma, breast cancer, kidney clear cell carcinoma, and uveal melanoma. • In the case of breast cancer, the 9-gene classifier serves as a potential biomarker for assessing the efficacy of adjuvant chemotherapy. • The 9-gene classifier showed better predictive accuracy than the recently developed prognostic gene signatures. Distant metastasis of soft tissue sarcoma (STS) is a risk factor with a significant impact on patient prognosis. Therefore, accurate prediction of STS metastatic risk is important in the therapeutic management of STS patients. In this study, we investigated gene expression profile of STS samples in public databases to comprehensively search for genes involved in distant metastasis. We then developed a 9-gene classifier that divided STS patients into four clusters with different metastatic risk. Interestingly, this classifier could also predict the metastatic risk of breast cancer, kidney clear cell carcinoma, and uveal melanoma. A comparison of AUC scores showed that the robustness of the 9-gene classifier was superior to many other existing prognostic gene signatures. In summary, the 9-gene classifier might provide useful prognostic information for the therapeutic management of STS and multiple other malignancies.
No takes yet. Share an insight, caveat, or question.
Tanabe et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: